Skip to main content
. 2015 Oct 11;25:1245–1255. doi: 10.1007/s11136-015-1154-9

Table 1.

Baseline characteristics of patients

All patients n = 143 Death or hospital readmission
Yes
n = 61
No
n = 82
Clinical data
 Age—years 68 ± 12 71 ± 11 66 ± 13
 Male—no (%) 106 (74.1) 46 (75.4) 62 (75.6)
 Body mass index (kg/m2) 27.0 ± 4.8 26.9 ± 3.7 27.0 ± 5.5
 Systolic blood pressure (mmHg) 113 ± 26 112 ± 20 114 ± 29
 Diastolic blood pressure (mmHg) 69 ± 17 67 ± 14 70 ± 19
 NYHA class III–IV—no (%) 83 (58.0) 41 (67.2) 43 (52.4)
Risk factors
 Hypercholesterolemia—no (%) 74 (51.7) 34 (55.7) 40 (48.8)
 Hypertension—no (%) 82 (57.3) 31 (50.8) 51 (62.2)
 Diabetes—no (%) 47 (32.9) 22 (36.1) 25 (30.5)
 Smoker within past 12 months—no (%) 37 (25.9) 12 (19.7) 25 (30.5)
Six-Minute Walk Test—median (IQR) 290 (200–380) 219 (160–311) 300 (238–420)
Biological dataa
 Brain natriuretic peptide (pg/ml) 741.3 (3.2) 853.9 (3.2) 621.0 (3.2)
 Glucose (mg/dl) 107.2 (1.3) 109.2 (1.4) 105.7 (1.3)
 Cholesterol (mg/dl) 147.9 (1.3) 137.1 (1.3) 156.9 (1.4)
 LDL cholesterol (mg/dl) 79.4 (1.5) 70.5 (1.5) 84.0 (1.6)
 Creatinine (mg/dl) 1.44 (1.45) 1.48 (1.48) 1.34 (1.35)
Left ventricular ejection fraction (%) 28 ± 7 28 ± 8 28 ± 7
Renal failure—no (%) 11 (7.7) 7 (11.5) 4 (4.9)
Chronic obstructive pulmonary disease—no (%) 22 (15.4) 11 (18.0) 11 (13.4)

Plus minus data are mean ± SD

NYHA New York Heart Association, LDL low-density lipoprotein

aData are geometric means (SD)